UNCY Insider Trading Activity and SEC Form 4 Filings
UNCY insider trading summary
No open-market insider purchases or sales of Unicycive Therapeutics, Inc. (UNCY) have been reported on SEC Form 4 in the past 12 months.
Latest UNCY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 16, 2022 | Brigitte Schiller | Director | Buy | $12K (15,000 @ $0.82) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.